About Us

Source BioScience is an international provider of integrated state of the art Laboratory Services. Headquartered in the UK, with offices in UK, Europe and the USA, Source BioScience is a fully owned subsidiary of SourceBio International plc, which listed on the AIM market of the London Stock Exchange in October 2020.


Serving a variety of markets, our multidisciplinary expertise includes:

  • Outsourced Histopathology Reporting Services & Human Tissue Testing Services
  • NGS (Next Generation Sequencing) & Sanger Sequencing Services
  • Stability Storage Solutions

Supporting the Healthcare System

Source Pathology Services provides a complete histopathology and clinical diagnostics service for cut up, processing and reporting of pre-prepared slides, blocks and wet surgical specimens through our accredited laboratories ISO15189:2012 - medical laboratories standard. Source Pathology Tailors its services through scalable solutions for laboratories whether that is within an NHS Trust or private hospital provider. 

A Global Leader for Genomic Services

We offer a comprehensive portfolio of genomic services, on a variety of prominent platforms.

With capabilities including Sanger sequencing, Next-generation sequencing, Microarray analysis, Genotyping and Bioinformatics, our dedicated team of professionals will support your research from RNA/DNA extraction, through to analysis and interpretation of your data.

Stability Storage Solutions

We deliver outsourced controlled environment storage for stability trials at all World Climatic ICH conditions, as well as bespoke conditions. In addition, we offer photostability testing facilities, biostorage capabilities, contingency storage for disaster recovery and facilities for the conservation of heritage items and other precious materials. Some special projects can be considered.